Gilead Sciences has significantly expanded its footprint in the immunology and inflammatory bowel disease (IBD) therapeutic landscapes through a multi-billion-dollar…
Read More
Gilead Sciences and Vir Biotechnology Expand Strategic Oncology Partnership in Multi-Billion-Dollar T-Cell Engager Deal for Solid Tumors
Gilead Sciences and Vir Biotechnology have significantly expanded their strategic research and development alliance through a newly finalized licensing agreement…
Read More
ELRIG Drug Discovery 2026 Marks Two Decades of Innovation as Europe’s Premier Life Sciences Event Returns to London
The European Laboratory Research and Innovation Group (ELRIG) is preparing to host its flagship milestone event, ELRIG Drug Discovery 2026,…
Read More
Navigating the Regulatory Crucible: Why Systemic Data Integrity Failures Continue to Dominate FDA Enforcement Actions in the Life Sciences Sector
When a warning letter from the United States Food and Drug Administration (FDA) arrives at a pharmaceutical manufacturer or medical…
Read More
Gilead Sciences and PAHO Partner to Expand Twice-Yearly Lenacapavir PrEP Access Across Latin America and the Caribbean
The landscape of global human immunodeficiency virus (HIV) prevention is undergoing a critical transformation following a landmark agreement between biopharmaceutical…
Read More
UK Life Sciences Sector Faces Funding Crisis Despite Government Prioritisation
The United Kingdom’s ambitious plans to foster growth within its vital life sciences sector are facing significant headwinds, with industry…
Read More
Salesforce Lands 140 Life Sciences Clients, Pitches ‘Headless’ AI to Pharma
As Peter Gassner, CEO of Veeva Systems, the long-established cloud software provider dominating the life sciences industry, prepared to take…
Read More
Rubedo Life Sciences’ RLS-1496 Shows Promise in Treating Precancerous Skin Lesions with Minimal Irritation
For millions worldwide grappling with actinic keratoses (AK), the rough, scaly patches of sun-damaged skin that are precursors to squamous…
Read More
US Life Sciences Investment Woes Leave Nation Vulnerable as China Cultivates Future Big Pharma Competitors
San Diego, CA – The landscape of global biopharmaceutical innovation is undergoing a significant shift, with concerns mounting among investors…
Read More
Salesforce Lands 140 Life Sciences Clients, Pitches ‘Headless’ AI to Pharma
Boston, MA – As Peter Gassner, CEO of Veeva Systems, a dominant cloud software provider in the life sciences sector,…
Read More
